Phosphonated agents and their antiangiogenic and antitumorigenic

Details Phosphonated agents and their antiangiogenic and antitumorigenic Phosphonated agents and their antiangiogenic and antitumorigenic

1998-07-23

2000-08-01

Geist, Gary

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

514114, 514115, 514116, 562 12, 562 13, 562 15, 562 23, A61K 3342

Patent

active

060967307

ABSTRACT:
Phosphonic acid agents are synthesized and characterized which are potent inhibitors of angiogenesis, tumorigenesis and metalloproteinase activity. Their method of use for the inhibition of angiogenesis and metalloproteinase and the treatment of tumors is also shown.

REFERENCES:
patent: 5652227 (1997-07-01), Teronen
patent: 5670493 (1997-09-01), Cordi
CA:82:4363 abs of Z Anorg Allg Chem by Issleib, K., 408(3), pp. 266-274, 1974.
CA:107:190405 ab of J Gen Virol by Jentsch, K, 68 (8), pp. 2183-2192, 1987.
CA:120:182336 ab of Antiviral Res by Oesterle R, 22(2-3), pp. 107-119, 1993.
CA:124:44745 ab of Cancer Res by Firsching A., 55(21) pp. 4757-4961, 1995.
CA:77:34992 ab of Sin. Fiz-Khim Polim., by Bakhitov M., No. 8 pp. 36-41, 1971.
Firsching et al., "Antiproliferative and Angiostatic Activity of Suramin Analogues.sup.1 ", Nov. 1, 1995, Cancer Research 55, 4957-4961.
Sola et al., "Antitumor activity of FCE 26644 a new growth-factor complexing molecule", Cancer Chemother Pharmacol (1995) 36:217-222.
Ciomei et al., "New Sulfonated Distamycin a Derivatives with bFGF Complexing Activity", Biochemical Pharmacology, vol. 47, No. 2, pp. 295-302, 1994.
Klaus Dieter Jentsch et al., "Inhibition of Human Immunodeficiency Virus Type I Reverse Transcriptase by Suramin-related Compounds", J. gen. Virol. (1987), vol. 68, pp. 2183-2192.
Reinhard Oesterle et al., "Chemical modifications of aminonaphthalenesulfonic acid derivatives increase effectivity and specificity of reverse transcriptase inhibition and change mode of action of reverse transcriptase and DNA polymerase alpha inhibition", Antiviral Research (1993), vol. 22, pp. 107-119.
Angela Firsching et al., "Antiproliferative and Angiostatic Activity of Suramin Analogues.sup.1 ", Cancer Research, vol. 55, Nov. 1, 1995, pp. 4957-4961.
Database CAPLUS on STN, Chemical abstracts (Columbus, Ohio), CA No. 126:157635, Cordi et al. "Preparation of aminophenylphosponic acid derivatives, pharmaceutical compositions containing them and their angiogenesis inhibitor activity", abstract EP 754693 A2, Jan. 22, 1997.
128:271686 (MARPAT), "Phosgenation Method in Production of Dyes and Intermediates", Xiaojun Peng et al., Faming Zhuanli Shengqing Gongkai Shuomingshu, 6 pp., 1998.

Affiliated with

Also associated with

Rating

Phosphonated agents and their antiangiogenic and antitumorigenic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphonated agents and their antiangiogenic and antitumorigenic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphonated agents and their antiangiogenic and antitumorigenic will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-664042